Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Global Blood Therapeutics"
Count: 34
Selected: 0
| NCT ID | Title |
|---|
| NCT05561140 | Resolution of Sickle Cell Leg Ulcers With Voxelotor | ||
| NCT03573882 | Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 | ||
| NCT04188509 | Open-Label Extension of Voxelotor | ||
| NCT04930328 | Retrospective Real World Oxbryta® Data Collection and Analysis Study | ||
| NCT04247594 | Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD | ||
| NCT02850406 | Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease | ||
| NCT04927247 | A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises | ||
| NCT05036512 | A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants | ||
| NCT04935879 | A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises | ||
| NCT04218084 | Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease | ||
| NCT05431088 | A Study in Adult and Pediatric Participants With Sickle Cell Disease (SCD) | ||
| NCT04983264 | A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD) | ||
| NCT05348915 | A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease | ||
| NCT04400487 | Actigraphy Improvement With Voxelotor (ActIVe) Study | ||
| NCT04930445 | Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD | ||
| NCT05228834 | Voxelotor Neurocognitive Function Study | ||
| NCT05228821 | Voxelotor Cerebral Hemodynamics Study | ||
| NCT04724421 | Expanded Access Protocol for Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options | ||
| NCT03036813 | Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE) | ||
| NCT02846324 | Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF | ||
| NCT02989168 | Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest | ||
| NCT03943615 | Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options | ||
| NCT03051711 | Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions | ||
| NCT03041909 | An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001 | ||
| NCT03114540 | Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment | ||
| NCT03161015 | Single-Dose PK Study of GBT440 in Subjects With Renal Impairment | ||
| NCT02285088 | A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease | ||
| NCT02567695 | A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects | ||
| NCT02567682 | Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects | ||
| NCT02497924 | A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects | ||
| NCT05018728 | The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia | ||
| NCT04335721 | A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease | ||
| NCT05199766 | Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor | ||
| NCT04581356 | Voxelotor Sickle Cell Exercise Study |
